These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9730170)

  • 1. Activated protein C resistance, factor V Leiden, and retinal vessel occlusion.
    Ma AD; Abrams CS
    Retina; 1998; 18(4):297-300. PubMed ID: 9730170
    [No Abstract]   [Full Text] [Related]  

  • 2. Retinal vascular occlusion and deficiencies in the protein C pathway.
    Gamel J
    Am J Ophthalmol; 2000 Jan; 129(1):112-3. PubMed ID: 10653431
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor V Leiden, activated protein C resistance, and retinal vein occlusion.
    Ciardella AP; Yannuzzi LA; Freund KB; DiMichele D; Nejat M; De Rosa JT; Daly JR; Sisco L
    Retina; 1998; 18(4):308-15. PubMed ID: 9730172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal vascular occlusion and deficiencies in the protein C pathway.
    Vine AK
    Am J Ophthalmol; 2000 Jan; 129(1):113-5. PubMed ID: 10653432
    [No Abstract]   [Full Text] [Related]  

  • 5. Arterial vascular occlusion associated with factor V Leiden gene mutation.
    Tayyanipour R; Pulido JS; Postel EA; Lipkowitz JL; Pisciotta A; Braza E
    Retina; 1998; 18(4):376-7. PubMed ID: 9730184
    [No Abstract]   [Full Text] [Related]  

  • 6. Bilateral retinal vein occlusion associated with factor V Leiden mutation.
    Spagnolo BV; Nasrallah FP
    Retina; 1998; 18(4):377-8. PubMed ID: 9730185
    [No Abstract]   [Full Text] [Related]  

  • 7. Retinal vascular occlusion and deficiencies in the protein C pathway.
    Greiner K; Hafner G; Dick B; Peetz D; Prellwitz W; Pfeiffer N
    Am J Ophthalmol; 1999 Jul; 128(1):69-74. PubMed ID: 10482096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion.
    Hvarfner C; Hillarp A; Larsson J
    Br J Ophthalmol; 2003 Mar; 87(3):305-6. PubMed ID: 12598443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central retinal artery occlusion in a patient homozygous for factor V Leiden.
    Larsson J
    Am J Ophthalmol; 2000 Jun; 129(6):816-7. PubMed ID: 10927002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance.
    Greven CM; Wall AB
    Am J Ophthalmol; 1997 Nov; 124(5):687-9. PubMed ID: 9372725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retinal artery occlusion and anterior ischemic optic neuropathy associated with factor V Leiden mutation: A case report].
    Elleuch IE; Sayadi S; Rahali N; Dridi T; Zbiba W
    J Fr Ophtalmol; 2020 Apr; 43(4):294-297. PubMed ID: 32107025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults.
    Gottlieb JL; Blice JP; Mestichelli B; Konkle BA; Benson WE
    Arch Ophthalmol; 1998 May; 116(5):577-9. PubMed ID: 9596492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal arterial occlusion in a child with factor V Leiden and thermolabile methylene tetrahydrofolate reductase mutations.
    Talmon T; Scharf J; Mayer E; Lanir N; Miller B; Brenner B
    Am J Ophthalmol; 1997 Nov; 124(5):689-91. PubMed ID: 9372726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation factor V and thrombophilia: background and mechanisms.
    Segers K; Dahlbäck B; Nicolaes GA
    Thromb Haemost; 2007 Sep; 98(3):530-42. PubMed ID: 17849041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombophilia factors as inducers of retinal vascular occlusion].
    Lerche RC; Wilhelm C; Eifrig B; Richard G
    Ophthalmologe; 2001 Jun; 98(6):529-34. PubMed ID: 11450475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branch retinal arteriolar occlusion associated with familial factor V Leiden polymorphism and positive rheumatoid factor.
    Dhar-Munshi S; Ayliffe WH; Jayne D
    Arch Ophthalmol; 1999 Jul; 117(7):971-3. PubMed ID: 10408469
    [No Abstract]   [Full Text] [Related]  

  • 17. Protein S deficiency with homozygous factor V Leiden mutation in central retinal vein occlusion.
    Sucak GT; Aki Z; Or M
    Can J Ophthalmol; 2007 Aug; 42(4):632-3. PubMed ID: 17641719
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion.
    Johnson TM; El-Defrawy S; Hodge WG; Leonard BC; Kertes PJ; Taylor SAM ; Lillicrap DP
    Retina; 2001; 21(2):161-6. PubMed ID: 11321143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant therapy after retinal vein occlusion in patients with protein S deficiency (Protein S deficiency with homozygous factor V Leiden mutation in central retinal vein occlusion. Vol. 42[4]).
    Rehak M; Krcova V; Slavik L; Müller M; Rehak J
    Can J Ophthalmol; 2007 Dec; 42(6):875; author reply 876. PubMed ID: 18059510
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor V Leiden: to test or not to test, that is the debate.
    Makris M
    Blood Transfus; 2012 Jul; 10(3):255-6. PubMed ID: 22889814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.